Skip to content

Medical emergency? What to do

Drug company proposes FDA check all drug advertising prior to marketing

3-RXPublished November 3, 20052 min read

Key points

  • Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S.
  • The FDA is presently considering revising the rules about how much risk information prescription drug commercials must include and whether all consumer-directed advertisements must be reviewed before they circulate.
  • AstraZeneca has been the subject of lawsuits filed by consumer groups and the AFL-CIO, which allege the company misled patients into switching to the more expensive Nexium as the patent on its nearly identical, older Prilosec pill was about to expire.
  • Crestor had been promoted as a multibillion-dollar seller for AstraZeneca, but persistent questions about its safety profile have resulted in disappointing sales.

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

Apparently the Anglo-Swedish company has made the recommendation in letter submitted to the FDA's public hearing on consumer-directed promotion of regulated medical products.

The FDA is presently considering revising the rules about how much risk information prescription drug commercials must include and whether all consumer-directed advertisements must be reviewed before they circulate.

According to AstraZeneca the company has adopted an industry group's guidelines on direct-to-consumer advertisements, and the principles are reflected in its TV ads for cholesterol pill Crestor and gastric acid treatment Nexium which was launched earlier this year.

AstraZeneca has been the subject of lawsuits filed by consumer groups and the AFL-CIO, which allege the company misled patients into switching to the more expensive Nexium as the patent on its nearly identical, older Prilosec pill was about to expire.

A U.S. Attorney last year requested company documents related to the formulary status of Prilosec and Nexium.

Crestor had been promoted as a multibillion-dollar seller for AstraZeneca, but persistent questions about its safety profile have resulted in disappointing sales.

Currently drugmakers are required by law to submit promotional material for FDA review at the time of circulation.

While some manufacturers voluntarily provide them earlier, the agency is considering whether that should be mandatory.

The Pharmaceutical Research and Manufacturers of America (PhRMA) in August released voluntary ad guidelines that include plans to voluntarily submit ads to the FDA sooner and to provide more balanced risk information.

The FDA is also considering whether makers of medical devices, most of which currently are not subject to FDA promotional regulations, must submit ads for review and face penalties for misleading or false materials.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.